EPA Focused Algae Omega-3 Ingredient Market - Growth, Trends And Forecast (2020 - 2025)
|出版商||Mordor Intelligence Pvt Ltd||商品編碼||649817|
|出版日期||內容資訊||英文 100 Pages
|EPA濃縮型·藻類Omega-3脂肪酸的全球市場:成長·趨勢·預測 EPA Focused Algae Omega-3 Ingredient Market - Growth, Trends And Forecast (2020 - 2025)|
|出版日期: 2020年05月01日||內容資訊: 英文 100 Pages||
本報告提供全球EPA (二十碳五烯酸) 濃縮型·藻類Omega-3脂肪酸的市場相關分析，提供產品概要·特性，及市場基本結構，主要的推動及阻礙市場要素，各濃度·不同形狀·各用途·各地區的市場趨勢預測，主要企業的簡介，今後的投資機會/市場成長機會等調查。
The global EPA focused algae omega-3 ingredient market is growing at a CAGR of 8.2% during the forecast period (2020-2025).
Omega-3 oils are essential fatty acids that have a broad range of health benefits, including cardiovascular, eye and brain health, for which is it is widely used in the various end-user application, like dietary supplements, infant nutrition, functional food and beverages, and pharmaceutical and clinical nutrition.
The EPA market is majorly driven by robust demands from the dietary supplements sector wherein an increasing amount of EPA is channelized in developing adult-based essential omega-3 supplements. Also, its robust application in different sectors such as infant formula, dietary supplement, fortified food and beverages, animal nutrition, and pharmaceuticals have further fueled the global market growth.
However, few of the regulations from the regulatory bodies are the factors restraining the global market growth. For instance, according to the IEG (International Expert Group) recommendations, the content of EPA in infant formula should not exceed the DHA content, which is creating a barrier for key players who are willing to introduce EPA-based infant formula products.
Demand For EPA In Infant Formulae & Functional Food And Beverages To Drive The Market
The extensive use of EPA in combination for developing effective infant nutrition solutions and functional food and beverages is found to boost the global algae omega-3 ingredient market. The vast body of scientific evidence supporting the role of EPA in*infants' cognitive and visual development*has further fueled infant formulae in the global marketplace. For instance, a plethora of new research and clinical studies have conclusively demonstrated that low EPA and DHA is a strong risk factor for preterm birth. Also, many foods such as milk, yogurt, margarine, bread, and chocolates are found to be increasingly fortified with EPA as supplying of omega-3 fatty acids in the diet, through fortified foods are expected to effectively meet the body's metabolic needs, better than dietary supplements.
Asia Pacific To Witness The Fastest Growth In The Global Market
Asia- Pacific is the fastest-growing regions for the algae omega-3 ingredient market with major markets of India and Australia. The Indian EPA market is driven by rich fish biodiversity that acts as an ideal source and abysmally low level of EPA in Indian diets that necessitates its consumption through nutraceuticals. Also, the dietary supplements sector in the Indian marketplace is expected to emerge as a lucrative application sector for EPA ingredients amid an increase in discretionary spending. The favoring regulations imposed by the regulatory bodies have further fueled the market of the region. For instance, the National Heart Foundation of Australia recommends EPA in the range of 500-1200 mg per day for reducing the risk of cardiovascular diseases and hypertriglyceridemia.
The global market for EPA focused algae omega-3 ingredient is fragmented, owing to the presence of a large number of regional and domestic players in different countries. Emphasis is given on the merger, expansion, acquisition, and partnership of the companies along with new product development as strategic approaches adopted by the leading companies to boost their brand presence among consumers. For instance, Croda International PLC, acquired Nautilus Biosciences Canada Inc., a marine biotechnology company based in Charlottetown, in 2018, so as to utilize its innovative science for applications across all Crodas' market sectors. Also, BASF Newtrition Omega-3 launched Accelon absorption-accelerating technology, to enable more omega-3's bioavailability in 2017.